Abstract:Siou-Min Luo, 1 Yi-Ping Wu, 2 Li-Chun Huang, 2 Shih-Ming Huang, 1, 2 Dueng-Yuan Hueng 1– 3 1 Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, Republic of China; 2 Department of Biochemistry, National Defense Medical Center, Taipei, Taiwan, Republic of China; 3 Department of Neurological Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China Correspondence: Dueng-Yuan Hueng Department of Neurological Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China Tel +886-2-8792-3100 #18802 Email Purpose: Glioblastoma multiforme (GBM) is the primary aggressive malignancy of the brain with poor outcome. Curcumin analogues are polyphenolic compounds as the bioactive substances extracted from turmeric. This study aims to investigate the anti-cancer effects of four curcumin analogues. Furthermore, the molecular mechanisms of dimethoxycurcumin in human gliomas were analyzed by Western blot. Materials and Methods: Human LN229 and GBM8401 glioma cells were treated by four curcumin analogues with different number of methoxy groups. The cell viability, cell cycle, apoptosis, proliferation and ROS production of human gliomas were analyzed by flow cytometry. Moreover, the effects of four curcumin analogues on tumorigenesis of gliomas were conducted by wound healing assay and colony formation assay. Furthermore, the molecular mechanisms of dimethoxycurcumin in human gliomas were analyzed by Western blot. Results: Our data showed that four different curcumin analogues including curcumin, bisdemethoxycurcumin, demethoxycurcumin, and dimethoxycurcumin promote sub-G1 phase, G2/M arrest, apoptosis, and ROS production in human glioma cells. Moreover, dimethoxycurcumin suppressed cell viability, migration, and colony formation, induction of sub-G1, G2/M arrest, apoptosis, and ROS production in glioma cells. Moreover, the mechanism of dimethoxycurcumin is ROS production to increase LC3B-II expression to induce autophagy. Furthermore, dimethoxycurcumin suppressed apoptotic marker, BCL-2 to promote apoptosis in LN229 and GBM8401 glioma cells. Conclusion: Our study found that dimethoxycurcumin induced apoptosis, autophagy, ROS production and suppressed cell viability in human gliomas. Dimethoxycurcumin might be a potential therapeutic candidate in human glioma cells. Keywords: curcumin, bisdemethoxycurcumin, demethoxycurcumin, dimethoxycurcumin, glioblastoma Glioblastoma multiforme (GBM) is the primary aggressive malignancy of the brain. Current standard treatment includes concurrent chemoradiotherapy after surgical resection methods have been the treatments. 1 Since the cell biology of human glioma possesses invasiveness, angiogenesis, and high proliferation leading to poor survival. 2 , 3 Therefore, the study of a new compound to improve cell biology in patients with glioblastomas is mandatory. Curcuminoids have many pharmacological activities used in Ayurvedic and Chinese medicine for centuries. 4 Curcumin can pass through the blood-brain barrier (BBB) and is detectable in cerebrospinal fluid of mouse model. 5 Curcumin, which is reported to target several signaling pathways mediated by p53, Ras, PI3K, and AKT in breast cancer. 6 Curcumin induced G2/M phase arrest and suppresses Wnt/β-catenin signaling pathway to reduce cell proliferation in medulloblastoma. 7 Curcuminoids belong to polyphenolic compounds containing about 77% pure curcumin (Cur), 17% demethoxycurcumin (DMC) and 3% bisdemethoxycurcumin (BisDMC). Curcuminoids are bioactive substances extracted from turmeric (Curcuma longa Linn). 8 A previous study reported that demethoxycurcumin increases lung cancer cell DNA damage to reduce DNA repair-related proteins. 9 Demethoxycurcumin suppresses NF-κB pathways to inhibit migration and invasion in HeLa cells. 10 Bisdemethoxycurcumin inhibits PI3K/AKT signaling to sensitize chemotherapy in cisplatin-resistant lung cancer cells. 11 Bisdemethoxycurcumin inhibits ovarian cancer cell through MMPs expressions to reduce oxidative stress. 12 Bisdemethoxycurcumin inactive AKT to inhibit the proliferation of hepatocellular carcinoma through CYLD-mediated deubiquitination. 13 Curcumin, demethoxycurcumin, and bi -Abstract Truncated-

Apoptotic Effect of Gemini Curcumin on MDA-MB-468 Breast Cancer Cell Line

Nanoformulation of Polyphenol Curcumin Enhances Cisplatin-Induced Apoptosis in Drug-Resistant MDA-MB-231 Breast Cancer Cells

The Cytoprotective Role Of Gemcitabine-Induced Autophagy Associated With Apoptosis Inhibition In Triple-Negative Mda-Mb-231 Breast Cancer Cells

Curcumin loaded on graphene nanosheets induced cell death in mammospheres from MCF-7 and primary breast tumor cells

Gallic acid and curcumin induce cytotoxicity and apoptosis in human breast cancer cell MDA-MB-231

Curcumin Induces Apoptosis in Gallbladder Carcinoma Cell Line GBC-SD Cells

Application of a novel pH-responsive gemini surfactant for delivery of curcumin molecules

Bisdemethoxycurcumin exerts pro-apoptotic effects in human pancreatic adenocarcinoma cells through mitochondrial dysfunction and a GRP78-dependent pathway.

Curcumin Induces Apoptosis Through the Mitochondria-Mediated Apoptotic Pathway in HT-29 Cells

Bisdemethoxycurcumin Potentiates Gemcitabine to Induce Mitochondrial Dysfunctions and Apoptosis in Human Pancreatic Adenocarcinoma Cells

Synergistic effect of curcumin and tamoxifen loaded in pH-responsive gemini surfactant nanoparticles on breast cancer cells

[Apoptosis Induced by Curcumin and Its Effect on C-Myc and Caspase-3 Expressions in Human Melanoma A375 Cell Line].

Curcumin inhibits autocrine growth hormone-mediated invasion and metastasis by targeting NF-κB signaling and polyamine metabolism in breast cancer cells

Novel curcumin nanoformulation induces apoptosis, and reduces migration and angiogenesis in liver cancer cells

The Anti-Cancer Effect of Four Curcumin Analogues on Human Glioma Cells

Cellular Effect of Curcumin and Citral Combination on Breast Cancer Cells: Induction of Apoptosis and Cell Cycle Arrest

Efficient Biocompatible Drug Carrier: Lignin-Based Nanogel Amplifies Curcumin's Cytotoxic Effects and Induces Apoptosis in Brain and Stomach Cancer Cell Lines

The role of the vascular endothelial growth factor/vascular endothelial growth factor receptors axis mediated angiogenesis in curcumin-loaded nanostructured lipid carriers induced human HepG2 cells apoptosis.

Curcumin Inhibits Cell Viability by Inducing Apoptosis and Autophagy in Human Colon Cancer Cells

Curcumin inhibits the invasion and metastasis of triple negative breast cancer via Hedgehog/Gli1 signaling pathway

Synthetic curcumin derivative DK1 possessed G2/M arrest and induced apoptosis through accumulation of intracellular ROS in MCF-7 breast cancer cells